In the first head-to-head comparison of leading incretin-based therapies, Eli Lilly’s dual GIP/GLP-1 receptor agonist ...

A new Salk Institute study suggests that estrogen-related receptors could be a key to repairing energy metabolism and muscle ...

Recent research published in PLOS One revealed a key mechanism driving acute to chronic muscle pain and demonstrated how ...

A new Salk Institute study suggests estrogen-related receptors could be a key to repairing energy metabolism and muscle ...

A panelist discusses how axatilimab, a humanized IgG4 monoclonal antibody targeting CSF-1 receptors on monocytes and macrophages, showed promising results in the AGAVE-201 trial for ...

Zealand Pharma A/S' obesity drug pipeline, including petrelintide, shows promise but faces high risks. Click to explore ZLDPF ...

A new Salk Institute study suggests estrogen-related receptors could be a key to repairing energy metabolism and muscle ...

A new Salk Institute study suggests estrogen-related receptors could be a key to repairing energy metabolism and muscle fatigue.

Optimized treatment reduces the mortality risk associated with chronic heart failure, leading to improvements in both ...